Tomohiro Nakayama
-
- Hormonal Regulation and Hypertension 30
- Diabetes Treatment and Management 10
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology 15
-
- Renin-Angiotensin System Studies 20
- Heart Failure Treatment and Management 10
- Blood Pressure and Hypertension Studies 10
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 11
- Clinical Biochemistry top 5%
-
- Liver Disease Diagnosis and Treatment 10
- Co-authors
- Masayoshi SomaZhaoxia WangKatsuo KanmatsuseNaoyuki SatoSachio TsuchidaYoichi IzumiMikano SatoSatoshi Asai
- Journals
- SHILAP Revista de lepidopterología (3 papers)Gastroenterology (1 paper)PLoS ONE (1 paper)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Tomohiro Nakayama
211 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 140
- Endocrinology, Diabetes and Metabolism 766
- Biochemistry 286
- Cardiology and Cardiovascular Medicine 880
- Pharmacology 173
- Clinical Biochemistry 129
Countries citing papers authored by Tomohiro Nakayama
This map shows the geographic impact of Tomohiro Nakayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Nakayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Nakayama more than expected).
Fields of papers citing papers by Tomohiro Nakayama
This network shows the impact of papers produced by Tomohiro Nakayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Nakayama. The network helps show where Tomohiro Nakayama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomohiro Nakayama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2021 | 2 | |
| 8 | 2019 | 8 | |
| 9 | 2016 | 21 | |
| 10 | [Genetic factors of hypertension]. | 2013 | 2 |
| 11 | 2013 | 11 | |
| 12 | 2012 | 5 | |
| 13 | 2012 | 7 | |
| 14 | 2011 | 29 | |
| 15 | 2010 | 11 | |
| 16 | 2009 | 13 | |
| 17 | 2009 | 23 | |
| 18 | Isolation of the 5'-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction. | 2001 | 58 |
| 19 | [Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives]. | 2001 | 3 |
| 20 | Gastrointestinal absorption of recombinant human insulin-like growth factor-I in rats | 1996 | 2 |
About Tomohiro Nakayama
Tomohiro Nakayama is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Biochemistry, having authored 223 papers that have together received 3.6k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (30 papers), Renin-Angiotensin System Studies (20 papers), Eicosanoids and Hypertension Pharmacology (15 papers), Pharmacogenetics and Drug Metabolism (11 papers), Heart Failure Treatment and Management (10 papers), Diabetes Treatment and Management (10 papers), Blood Pressure and Hypertension Studies (10 papers) and Liver Disease Diagnosis and Treatment (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (766 citations), Biochemistry (286 citations) and Cardiology and Cardiovascular Medicine (880 citations). Tomohiro Nakayama has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Masayoshi Soma, Zhaoxia Wang, Katsuo Kanmatsuse, Naoyuki Sato, Sachio Tsuchida, Yoichi Izumi, Mikano Sato, Satoshi Asai, Noriko Aoi and Masanori Shimodaira. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.